Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Bisphosphonate Treatment of Osteogenesis Imperfecta

ClinicalTrials.gov ID: NCT00063479

Public ClinicalTrials.gov record NCT00063479. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00063479
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
158 participants

Conditions and interventions

Interventions

  • Zoledronic Acid Drug

Drug

Eligibility (public fields only)

Age range
3 Months to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2003
Primary completion
Apr 30, 2007
Completion
Apr 30, 2007
Last update posted
May 31, 2017

2003 – 2007

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
UCLA - Division of Pediatric Nephrology Los Angeles California 90024
Alfred I. DuPont Hospital for Children Wilmington Delaware 19899
Intermountain Orthopedics Boise Idaho 83702
St. Jude Children's Research Hospital Peoria Illinois 61637
Children's Hospital Omaha Nebraska 68198
Children's Hospital Medical Center Cincinnati Ohio 45229
Children's Hospital Columbus Ohio 43205
Oregon Health Sciences University Portland Oregon 97201
Vanderbilt University Medical Center Nashville Tennessee 37232
Texas Children's Hosptial Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00063479, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 31, 2017 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00063479 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →